The pandemic provided a reason to the stock market to be excited about the pharma sector that had been facing lacklustre prospects amid challenges in the US business, USFDA compliance issues, pricing pressure, big-bang acquisitions not working out on expected lines and modest growth in the domestic market.
Holi-to-Holi multibaggers: From market favourites to hidden gems, 80 stocks deliver up to 1,822% returns
Ahead of Holi 2026, several Indian stocks have emerged as multibaggers since last Holi, delivering exceptional returns despite market volatility. While strong performers span sectors